(<i>S</i>)-13-[(Dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16,21-dimetheno- 1<i>H</i>,13<i>H</i>-dibenzo[<i>e</i>,<i>k</i>]pyrrolo[3,4-<i>h</i>][1,4,13]oxadiazacyclohexadecene-1,3(2<i>H</i>)-dione (LY333531) and Related Analogues: Isozyme Selective Inhibitors of Protein Kinase Cβ
-
- Michael R. Jirousek
- Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
-
- James R. Gillig
- Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
-
- Cecile M. Gonzalez
- Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
-
- William F. Heath
- Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
-
- John H. McDonald
- Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
-
- David A. Neel
- Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
-
- Christopher J. Rito
- Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
-
- Upinder Singh
- Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
-
- Lawrence E. Stramm
- Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
-
- Anita Melikian-Badalian
- Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
-
- Matthew Baevsky
- Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
-
- Lawrence M. Ballas
- Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
-
- Steven E. Hall
- Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
-
- Leonard L. Winneroski
- Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
-
- Margaret M. Faul
- Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
書誌事項
- 公開日
- 1996-01-01
- DOI
-
- 10.1021/jm950588y
- 公開者
- American Chemical Society (ACS)
この論文をさがす
収録刊行物
-
- Journal of Medicinal Chemistry
-
Journal of Medicinal Chemistry 39 (14), 2664-2671, 1996-01-01
American Chemical Society (ACS)